Biogen Inc. buy Needham & Company LLC
Start price
25.07.23
/
50%
€242.80
Target price
25.07.24
€290.08
Performance (%)
-13.55%
End price
26.07.24
€209.90
Summary
This prediction ended on 26.07.24 with a price of €209.90. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.55%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | -6.604% | -6.604% | -18.640% |
iShares Core DAX® | 1.280% | 1.320% | 13.605% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $320.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten